Chordia Therapeutics (TSE:190A) Accounts Payable & Accrued Expense : 円144.29 Mil (As of Feb. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Accounts Payable & Accrued Expense?

Chordia Therapeutics's quarterly accounts payable & accrued expense increased from May. 2024 (円83.15 Mil) to Aug. 2024 (円436.72 Mil) but then declined from Aug. 2024 (円436.72 Mil) to Feb. 2025 (円144.29 Mil).

Chordia Therapeutics's annual accounts payable & accrued expense increased from Aug. 2022 (円142.45 Mil) to Aug. 2023 (円250.85 Mil) and increased from Aug. 2023 (円250.85 Mil) to Aug. 2024 (円436.72 Mil).

Chordia Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Chordia Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Accounts Payable & Accrued Expense Chart

Chordia Therapeutics Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Accounts Payable & Accrued Expense

96.60

142.45

250.85

436.72

Chordia Therapeutics Quarterly Data
	Aug21	Aug22	May23	Aug23	May24	Aug24	Feb25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			221.60	250.85	83.15	436.72	144.29

Chordia Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Chordia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012

Website

https://www.chordiatherapeutics.com

Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines